Article

Pathological Signature and Therapeutic Status of NSCLC Patients with Common or Rare Driver Gene Alterations in North China：A real world retrospective study

2020-05-22

Abstract excerpt

<h4>Background: </h4> Although guidelines recommended to test EGFR/ALK/ROS-1 gene alterations in advanced non-small cell lung cancer (NSCLC) patients before treatment, there is now growing evidence that rare driver genes and mutations also can inform targeted therapy and improve outcomes for this traditionally underrepresented population. This study aimed to describe mutational patterns and linked clinical paramet...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d3823494-4cc1-5039-a14e-3a4acf734617
DOI: 10.21203/rs.3.rs-30399/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Pathological Signature and Therapeutic Status of NSCLC Patients with Common or Rare Driver Gene Alterations in North China：A real world retrospective studyDOI 10.21203/rs.3.rs-30399/v1Read

Clinical features and outcomes of unresectable locally advanced non-small cell lung cancer with uncommon EGFR Mutations: A retrospective multi-center Chinese studySemantic proximity Read

Multicenter real-world data of patients harboring rare mutations other than EGFR or ALK in advanced or metastatic non-small cell lung cancer.Semantic proximity Read

Genomic characteristics of driver genes in Chinese patients with non‐small cell lung cancerSemantic proximity Read

[Driver genes and its clinical significance in non-small cell lung cancer].Semantic proximity Read

Efficacy of EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients harboring different types of EGFR mutations: A retrospective analysis.Semantic proximity Read

Driver gene alterations in NSCLC patients in southern China and their correlation with clinicopathologic characteristicsSemantic proximity Read

Characterization of common and rare mutations in EGFR and associated clinicopathological features in a large population of Chinese patients with lung cancer.Semantic proximity Read

Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung CancerSemantic proximity Read

Catalog of Lung Cancer Gene Mutations Among Chinese PatientsSemantic proximity Read

Molecular Epidemiology of the Main Druggable Genetic Alterations in Non-Small Cell Lung Cancer.Semantic proximity Read

Clinical Impact of EGFR Mutation Subtypes on Treatment Outcomes in Advanced Non-Small Cell Lung Cancer: An Austrian Real-World StudySemantic proximity Read

[Advances on driver oncogenes of non-small cell lung cancer].Semantic proximity Read